Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Clinical trial NCT00344318 · COMPLETED

Trial details

NCT number: NCT00344318
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Streptococcal

Start date: 2006-08-07
Primary completion: 2007-04-27
Enrollment: 806

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.